Interestingly and likely in line with our results, LAG3 expression levels on tumour infiltrating lymphocytes (TILs) of LC patients has been shown to correlate with early disease relapse and poor prognosis [40]. This evidence concerns the gene LAG3 and laryngotracheoesophageal cleft.